English
  1. Home
  2. Stocks
  3. Nathbiogen Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Nath Bio-Genes (India) Share Price Nath Bio-Genes (India)

    Small Cap
    ₹193.55
    -10.8 (-5.29%)
    09 May, 2024 20:31 BSE: 537291 NSE: NATHBIOGENISIN: INE448G01010

    Start SIP in Nath Bio-Genes (India)

    Start SIP

    Nath Bio-Genes (India) Performance

    Day Range

    • Low 192
    • High 205
    ₹ 193

    52 Week Range

    • Low 159
    • High 245
    ₹ 193
    • Open Price198
    • Previous Close204
    • Volume73531

    Nath Bio-Genes (India) Share Price

    • Over 1 Month +0.28%
    • Over 3 Month -12.44%
    • Over 6 Month +3.42%
    • Over 1 Year +15.59%

    Nath Bio-Genes (India) Key Statistics

    P/E Ratio 8.6
    PEG Ratio 0.4
    Market Cap Cr 368
    Price to Book Ratio 0.6
    EPS 18.5
    Dividend 1
    Relative Strength Index 45.83
    Money Flow Index 57.65
    MACD Signal 2.6
    Average True Range 7.66
    Nath Bio-Genes (India) Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 43322323545
    Operating Expenses Qtr Cr 39261719841
    Operating Profit Qtr Cr 466374
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 13232
    Tax Qtr Cr 11000
    Net Profit Qtr Cr 342332
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 333302
    Operating Expenses Annual Cr 282252
    Operating Profit Annual in Cr 5049
    Depreciation Cr 33
    Interest Annual Cr 910
    Tax Annual Cr 21
    Net Profit Annual Cr 4035
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 7538
    Cash from Investing Activity Annual Cr -27-3
    Cash from Financing Annual Activity Cr -10-2
    Net Cash Flow Annual Cr 34
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 611573
    Fixed Assets Annual Cr 249244
    Total Non Current Assets Annual Cr 309272
    Total Current Assets Annual Cr 569521
    Total Assets Annual Cr 877793
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 321302
    ROE Annual % 76
    ROCE Annual % 88
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1516
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 433223235
    Operating Expenses Qtr Cr 392617198
    Operating Profit Qtr Cr 46637
    Depreciation Qtr Cr 1111
    Interest Qtr Cr 1323
    Tax Qtr Cr 1100
    Net Profit Qtr Cr 34233
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 333302
    Operating Expenses Annual Cr 283253
    Operating Profit Annual in Cr 5049
    Depreciation Cr 33
    Interest Annual Cr 910
    Tax Annual Cr 21
    Net Profit Annual Cr 4035
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 7038
    Cash from Investing Activity Annual Cr -27-3
    Cash from Financing Annual Activity Cr -5-2
    Net Cash Flow Annual Cr 34
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 610573
    Fixed Assets Annual Cr 247244
    Total Non Current Assets Annual Cr 309272
    Total Current Assets Annual Cr 572521
    Total Assets Annual Cr 880793
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 321302
    ROE Annual % 66
    ROCE Annual % 88
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1516
    Sign Up to Know More
    Invest in Nath Bio-Genes (India)

    Nath Bio-Genes (India) Technicals

    EMA & SMA

    Current Price
    ₹193.55
    -10.8 (-5.29%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹198.37
    • 50 Day
    • ₹197.69
    • 100 Day
    • ₹199.69
    • 200 Day
    • ₹198.90
    • 20 Day
    • ₹198.04
    • 50 Day
    • ₹194.15
    • 100 Day
    • ₹203.48
    • 200 Day
    • ₹205.41

    Nath Bio-Genes (India) Resistance and Support

    PIVOT
    ₹196.79
    Resistance
    First Resistance 201.37
    Second Resistance 209.18
    Third Resistance 213.77
    RSI 45.83
    MFI 57.65
    MACD Single Line 2.60
    MACD 2.26
    Support
    First Resistance 188.97
    Second Resistance 184.38
    Third Resistance 176.57

    Nath Bio-Genes (India) Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 78,381 5,242,905 66.89
    Week 49,501 3,168,090 64
    1 Month 51,700 3,091,149 59.79
    6 Month 91,319 5,561,349 60.9

    Nath Bio-Genes (India) Result Highlights

    Nath Bio-Genes (India) Synopsis

    NSE-Agricultural Operations

    Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
    Market Cap 368
    Sales 333
    Shares in Float 1.03
    No of funds 14
    Yield 0.96
    Book Value 0.6
    U/D Vol ratio 0.9
    LTDebt / Equity
    Alpha -0.06
    Beta 1.39

    Nath Bio-Genes (India)

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 45.6%45.6%45.6%45.6%
    Mutual Funds 4.37%4.37%4.37%4.62%
    Foreign Portfolio Investors 0.27%0.32%0.22%0.07%
    Financial Institutions/ Banks
    Individual Investors 32.25%30.96%30.5%30.37%
    Others 17.51%18.75%19.31%19.34%

    Nath Bio-Genes (India) Management

    Name Designation
    Mr. Satish Kagliwal Managing Director
    Mr. Madhukar Deshpande Director
    Ms. Ashu Jain Director
    Mrs. Jeevanlata Kagliwal Director
    Mr. Vadla Nagabhushanam Director
    Mrs. Sweta Kagliwal Director
    Mr. Hitesh Purohit Director

    Nath Bio-Genes (India) Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nath Bio-Genes (India) Corporate Action

    Date Purpose Remarks
    2024-05-08 Audited Results & Final Dividend
    2024-01-18 Quarterly Results
    2023-10-16 Quarterly Results
    2023-08-10 Quarterly Results
    2023-04-22 Audited Results & Final Dividend

    Nath Bio-Genes (India) MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Pure Value Fund Growth 5,684

    Nath Bio-Genes (India) FAQs

    What is Share Price of Nath Bio-Genes (India) ?

    Nath Bio-Genes (India) share price is ₹193 As on 09 May, 2024 | 20:17

    What is the Market Cap of Nath Bio-Genes (India) ?

    The Market Cap of Nath Bio-Genes (India) is ₹367.8 Cr As on 09 May, 2024 | 20:17

    What is the P/E ratio of Nath Bio-Genes (India) ?

    The P/E ratio of Nath Bio-Genes (India) is 8.6 As on 09 May, 2024 | 20:17

    What is the PB ratio of Nath Bio-Genes (India) ?

    The PB ratio of Nath Bio-Genes (India) is 0.6 As on 09 May, 2024 | 20:17

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.